Gene · 1870
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Experimental Validation and Prediction of Super-Enhancers: Advances and Challenges. | Cells | 2023 | 37190100 | PubTator, text mining | PubMed |
| Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity. | Clin Transl Med | 2023 | 37186134 | PubTator, text mining | PubMed |
| The Potential Association between E2F2, MDM2 and p16 Protein Concentration and Selected Sociodemographic and Clinicopathological Characteristics of Patients with Oral Squamous Cell Carcinoma. | Curr Issues Mol Biol | 2023 | 37185737 | PubTator, text mining | PubMed |
| The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma. | Int J Mol Sci | 2023 | 37175660 | PubTator, text mining | PubMed |
| MiR-548 K regulatory effect on the ABCG2 gene expression in MDR breast cancer cells. | Cancer Rep (Hoboken) | 2023 | 37166017 | PubTator, text mining | PubMed |
| Lenvatinib resistance mechanism and potential ways to conquer. | Front Pharmacol | 2023 | 37153782 | PubTator, text mining | PubMed |
| Ferroptosis-associated circular RNAs: Opportunities and challenges in the diagnosis and treatment of cancer. | Front Cell Dev Biol | 2023 | 37152286 | PubTator, text mining | PubMed |
| The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer. | Acta Pharm Sin B | 2023 | 37139412 | PubTator, text mining | PubMed |
| Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma. | Cell Death Dis | 2023 | 37137887 | PubTator, text mining | PubMed |
| A review on the role of LINC00511 in cancer. | Front Genet | 2023 | 37124625 | PubTator, text mining | PubMed |
| Host gene and its guest: short story about relation of long-noncoding MIR31HG transcript and microRNA miR-31. | Rep Pract Oncol Radiother | 2023 | 37122913 | PubTator, text mining | PubMed |
| Sustained Shugoshin 1 downregulation reduces tumor growth and metastasis in a mouse xenograft tumor model of triple-negative breast cancer. | Cell Div | 2023 | 37122033 | PubTator, text mining | PubMed |
| Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients. | Sci Rep | 2023 | 37120674 | PubTator, text mining | PubMed |
| TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma. | Sci Adv | 2023 | 37115930 | PubTator, text mining | PubMed |
| Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA. | Int J Mol Sci | 2023 | 37108398 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophage-Derived Exosomal LINC01232 Induces the Immune Escape in Glioma by Decreasing Surface MHC-I Expression. | Adv Sci (Weinh) | 2023 | 37097629 | PubTator, text mining | PubMed |
| Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A. | J Cancer Res Clin Oncol | 2023 | 37097392 | PubTator, text mining | PubMed |
| Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer. | Clin Transl Oncol | 2023 | 37095423 | PubTator, text mining | PubMed |
| Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma. | Front Med (Lausanne) | 2023 | 37081847 | PubTator, text mining | PubMed |
| Macrophages and small extracellular vesicle mediated-intracellular communication in the peritoneal microenvironment: Impact on endometriosis development. | Front Reprod Health | 2023 | 37077181 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1870/papers?page=14